View Entire Collection
By Clinical Topic
By State Requirement
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
FRIDAY, July 30 (HealthDay News) -- The annual flu vaccine for the 2010-2011 influenza season has been approved by the U.S. Food and Drug Administration, the agency said Friday.
The yearly vaccine protects against the three strains predicted to be most prevalent in the United States. This year's shot includes protection against the H1N1 influenza that emerged in 2009. The specific strains are:
Brand names and manufacturers for the vaccine are: Afluria, CSL Limited; Agriflu, Novartis Vaccines and Diagnostics; Fluarix, GlaxoSmithKline Biologicals; FluLaval, ID Biomedical Corporation; FluMist, MedImmune Vaccines Inc.; Fluvirin, Novartis Vaccines and Diagnostics Limited; and Fluzone and Fluzone High-Dose, Sanofi Pasteur Inc.
"The best way to protect yourself and your family against influenza is to get vaccinated every year," said Karen Midthun, M.D., acting director of FDA's Center for Biologics Evaluation and Research, in a statement. "The availability of a new seasonal influenza vaccine each year is an important tool in the prevention of influenza related illnesses and death."
The FDA has more about this approval.
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top